Evaluating Quality of Life in Patients With AIDS-Associated Kaposi Sarcoma Treated With Bleomycin and Vincristine
Status:
Completed
Trial end date:
2020-06-13
Target enrollment:
Participant gender:
Summary
This pilot phase I trial studies how well treatment with vincristine and bleomycin affect
quality of life in patients with acquired immunodeficiency syndrome (AIDS)-associated Kaposi
sarcoma.
Phase:
Phase 1
Details
Lead Sponsor:
AIDS Malignancy Consortium
Collaborators:
National Cancer Institute (NCI) The Emmes Company, LLC The EMMES Corporation University of Arkansas University of California, Los Angeles